Results 241 to 250 of about 1,212,195 (296)

Notes from the Field: Potential Infant HIV Exposure from Donated Breast Milk Received Through Social Media - Santa Clara County, California, May 2025-January 2026. [PDF]

MMWR Morb Mortal Wkly Rep
Løchen A, Pang D, Howard S, Padilla R, Monterrosa L, Quintana IS, Klebba K, Iqbal S, Chua H, Cline T, Aguilar A, Bonin B, Roy M, Vaidya A.   +13 more
europepmc   +1 more source

Preferential engagement of the anti-inflammatory ATP/adenosine axis by HIV vaccine candidate with V1-deleted envelope in male rhesus macaques. [PDF]

Cell Rep Med
Silva de Castro I, Rahman MA, Bissa M, Goldfarbmuren KC, Schifanella L, Sarkis S, N'guessan KF, Ma ZM, Gutowska A, Stamos JD, Doster MN, Woode EK, Smith JC, Kozlowski PA, Williams LD, McKinnon KM, Tomaras GD, Shen X, Montefiori DC, Santra S, Paquin-Proulx D, Maldarelli F, Cardozo T, Franchini G.   +23 more
europepmc   +1 more source

Non-human primate LIBRA-Seq accelerates neutralizing antibody discovery in RM vaccinated against HIV-1. [PDF]

PLoS Pathog
Edwards CT, Silva-Trenkle AD, Sahoo A, Cruickshank K, Nelson S, Lapp SA, Raju N, Ton T, Metz A, McGhee E, Mbadugha FA, Charles TP, Saini A, Gill K, Pellegrini KL, Kong R, Wrammert J, Upadhyay AA, Derdeyn CA, Amara RR, Kwong G, Bosinger SE.   +21 more
europepmc   +1 more source

Structural basis of membrane engagement and polyreactivity control in HIV-1 MPER broadly neutralizing antibodies. [PDF]

Proc Natl Acad Sci U S A
Cho SY, Rantalainen K, Ozorowski G, Lu D, Tingle R, Lee WH, Ward AB, Schief WR, Wilson IA.   +8 more
europepmc   +1 more source

Structural determination of the HIV-1 Variable Region 3 epitope of antibody 19b. [PDF]

J Virol
Fetics SK, Mehta A, Nicely NI, Chen C-H(, Lindenberger J, Acharya P.   +5 more
europepmc   +1 more source

Broadly Neutralizing Antibodies for HIV Eradication [PDF]

Current HIV/AIDS Reports, 2016
Passive transfer of antibodies has long been considered a potential treatment modality for infectious diseases, including HIV. Early efforts to use antibodies to suppress HIV replication, however, were largely unsuccessful, as the antibodies that were ...
Dan H Barouch, Kathryn Stephenson
exaly   +2 more sources

Some of the next articles are maybe not open access.

Related searches:

Neutralization of HIV by Antibodies

2008
Antibodies can neutralize HIV-1 with potency and cross-reactivity that varies widely and is related but not correlated to their antigen-binding affinity. Therefore, in addition to measuring binding affinity, an evaluation of the antibody neutralizing activity in tissue cultures is important for development of antibody-based therapeutics, design of ...
Ilia, Prado, Timothy R, Fouts, Antony S, Dimitrov   +2 more
openaire   +2 more sources

The Role of Antibodies in HIV Vaccines

Annual Review of Immunology, 2010
Licensed vaccines against viral diseases generate antibodies that neutralize the infecting virus and protect against infection or disease. Similarly, an effective vaccine against HIV-1 will likely need to induce antibodies that prevent initial infection of host cells or that limit early events of viral dissemination.
John R, Mascola, David C, Montefiori
openaire   +2 more sources

Mucosal Antibody Responses to HIV

2009
The measurement of antibodies specific for the majority of infectious agents in various external secretions is important in the evaluation of potentially protective immune responses at various sites of pathogen entry. Importantly, due to differences in the isotypes of antibodies in various body fluids, levels of total and antigen-specific antibodies in
Zina, Moldoveanu, Jiri, Mestecky
openaire   +2 more sources

HIV Antibody in Lebanese Arabs

Annals of Internal Medicine, 1987
Excerpt To the editor: The prevalence of antibody to the human immunodeficiency virus (HIV) has been determined in various non-high-risk groups in different parts of the world.
openaire   +2 more sources